Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trial
Titel:
Neoadjuvant docetaxel, epirubicin, and cyclophosphamide with or without metformin in breast cancer patients with metabolic abnormality: results from the randomized Phase II NeoMET trial
Auteur:
Huang, Jiahui Tong, Yiwei Hong, Jin Huang, Ou Wu, Jiayi He, Jianrong Chen, Weiguo Li, Yafen Chen, Xiaosong Shen, Kunwei